World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
20462
World Ranking
18810
National Ranking
9379

Overview

Richard A. Nash is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on Medicine, with notable contributions to subfields including Pathology and Forensic Medicine, Neurology, Pulmonary and Respiratory Medicine, Immunology, and Epidemiology.

The scientist has published extensively on topics related to Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Mast Cells and Histamine, Inflammatory Myopathies and Dermatomyositis, Autoimmune Neurological Disorders and Treatments, Dermatologic Treatments and Research, and CNS Lymphoma Diagnosis and Treatment.

Frequent publication venues for their work include:

  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology
  • Trends in Ecology & Evolution
  • Annals of Clinical and Translational Neurology
  • Lara D. Veeken

Several recent papers by the scientist include:

  • Horizon Scan of the Belt and Road Initiative, 2020, Trends in Ecology & Evolution
  • Machine learning predicts stem cell transplant response in severe scleroderma, 2020, Annals of the Rheumatic Diseases
  • Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation, 2023, Annals of the Rheumatic Diseases
  • Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis, 2020, Arthritis & Rheumatology
  • Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis, 2022, Annals of the Rheumatic Diseases

The scientist has collaborated frequently with coauthors including:

  • Peter A. McSweeney
  • Daniel E. Furst
  • Maureen D. Mayes
  • Keith M. Sullivan
  • Ashley Pinckney

Best Publications

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.

    Rainer Storb;Cong Yu;John L. Wagner;H. Joachim Deeg

  • Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

    Richard A. Nash;Joseph H. Antin;Chatchada Karanes;Joseph W. Fay

  • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

    K. M. Sullivan;E. A. Goldmuntz;L. Keyes-Elstein;P. A. McSweeney

  • Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.

    R A Nash;M S Pepe;R Storb;G Longton

  • Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

    J.T. Slattery;R.A. Clift;C.D. Buckner;J. Radich

  • Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells.

    Vishwanath Bhattacharya;Peter A. McSweeney;Qun Shi;Benedetto Bruno

  • Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

    Sibel Koc;Wendy Leisenring;Mary E. D. Flowers;Claudio Anasetti

  • Duration of immunosuppressive treatment for chronic graft-versus-host disease.

    Betty L. Stewart;Barry Storer;Jan Storek;H. Joachim Deeg

  • High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

    Richard A. Nash;Richard A. Nash;Peter A. McSweeney;Leslie J Crofford;Muneer Abidi

  • High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

    Richard A. Nash;James D. Bowen;Peter A. McSweeney;Steven Z. Pavletic

  • T cell repertoire following autologous stem cell transplantation for multiple sclerosis.

    Paolo A. Muraro;Harlan Robins;Sachin Malhotra;Michael Howell

  • Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease

    A I Benito;T Furlong;P J Martin;C Anasetti

  • Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.

    Paolo A. Muraro;Marcelo Pasquini;Harold L. Atkins;James D. Bowen

  • Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

    H. Openshaw;O. Stuve;J.P. Antel;R. Nash

  • Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

    Jo N. Fleming;Richard A. Nash;D. O. McLeod;David F. Fiorentino

  • High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

    Peter A. McSweeney;Richard A. Nash;Keith M. Sullivan;Jan Storek

  • Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.

    Rainer Storb;Cong Yu;Todd Barnett;John L. Wagner

Frequent Co-Authors

Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Keith M. Sullivan
Keith M. Sullivan Duke University
Claudio Anasetti
Claudio Anasetti Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
Hans Peter Kiem
Hans Peter Kiem Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Ted Gooley
Ted Gooley Fred Hutchinson Cancer Research Center
Mary E.D. Flowers
Mary E.D. Flowers Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying medicine in the USA, exploring alternative or supplementary online degrees can help diversify your career options. For those seeking a swift entry into healthcare, lpn program options provide a fast-track route to becoming a licensed practical nurse, with many flexible online choices available.

Specializing in mental health is another in-demand path. Accredited psych nurse practitioner programs can be completed online, allowing registered nurses to advance with focused training in psychiatric and mental health care.

For those interested in healthcare management or administration, pursuing the cheapest online health science degree is a budget-friendly way to start. Meanwhile, if you are looking to move into leadership roles, consider the cost of mha degree before enrolling in an online master’s program. These diverse pathways offer greater flexibility and affordability while keeping you at the forefront of the evolving healthcare landscape.

Best Scientists Citing Richard A. Nash

Trending Scientists